British Sovereign AI Fund eyes £500M bet on AI-driven drug discovery startup
The British Sovereign AI Fund is negotiating a £500 million investment in an AI-powered drug discovery startup, aiming to accelerate R&D and boost UK biotech.
Insilico Medicine
Latest Insilico Medicine coverage.